3. Detecting and monitoring undesirable effects
Before a molecule can be granted marketing authorization and used in everyday practice, it must satisfy a whole series of scientific and regulatory requirements designed to protect patients. The development of a new drug involves two successive periods, preclinical and clinical, during which the molecule's efficacy and safety are assessed .
3.1 In preclinical studies
Safety conditions are defined by in vitro and animal toxicology...
Exclusive to subscribers. 97% yet to be discovered!
Already subscribed? Log in!
Detecting and monitoring undesirable effects
Post-AMM risk monitoring methods
Bibliography
Exclusive to subscribers. 97% yet to be discovered!
Already subscribed? Log in!
Article included in this offer
"Drugs and pharmaceuticals"
(
130 articles
)
Updated and enriched with articles validated by our scientific committees
A set of exclusive tools to complement the resources
